The government recently implemented a requirement for private clinics and pharmacies to display drug and medicine prices starting May 1, 2025 (Thursday). This regulation under the Price Control and Anti-Profiteering Act 2011 (Act 723) is an effort to increase price transparency and to empower consumers.
However, this has sparked protests among private doctors who question the requirement’s rationale and implications on health services.
According to a report by Sinar Harian, the new president of the Malaysian Medical Association (MMA), Datuk Dr R Thirunavukarasu, shared that many questions have been raised about the basis for the use of Act 723 and its implementation method.
Led by MMA, about 200 private doctors in collaboration with 11 medical associations gathered in front of the Perdana Putra building in Putrajaya on Tuesday (May 6) to submit a memorandum of protest to the Prime Minister, Datuk Seri Anwar Ibrahim.
Why are private doctors against the requirement to display drug and medicine prices?
Their main argument is the concern that patients may make treatment decisions solely based on price, not their actual medical needs.
They are also worried that the price comparisons between clinics and pharmacies can become misleading, as patients may not take into account the operating costs and professional consultations that are provided with medication at clinics.
Private doctors are concerned that the display of drug prices without a review of the consultation fees is unfair and could affect the continuity of their operations, especially in rural areas.
The display of drug and medicine prices is considered necessary
The President of the Congress of Unions of Public Service Employees (Cuepacs), Datuk Dr Adnan Mat, shared that the requirement is an effort to provide fairer and more affordable access to treatment for all levels of society.
He also emphasised that the policy does not constitute price control, but rather an initiative towards information transparency and the right of consumers to know the price of medicines sold.
Price transparency is also seen as important to avoid excessive charges and to ensure that patients are not burdened with unreasonable treatment costs.
What do you think about this? Do feel free to share your thoughts in the comment section.
